Insider Transactions in Q1 2022 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+11.95%
|
-
|
|
Feb 22
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.64%
|
-
|
|
Feb 03
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
52,056
-0.31%
|
$0
$0.73 P/Share
|
|
Feb 02
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,416
-0.07%
|
$0
$0.76 P/Share
|
|
Feb 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
288,320
-1.79%
|
$0
$0.78 P/Share
|
|
Feb 01
2022
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
133,776
+0.82%
|
$0
$0.75 P/Share
|
|
Feb 01
2022
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
79,896
-3.99%
|
$0
$0.78 P/Share
|
|
Feb 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
288,648
-1.68%
|
$0
$0.78 P/Share
|
|
Feb 01
2022
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
334,448
+1.91%
|
$0
$0.75 P/Share
|
|
Feb 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
63,560
-2.28%
|
$0
$0.78 P/Share
|
|
Feb 01
2022
|
Lisa Deschamps Director |
SELL
Open market or private sale
|
Direct |
11,664
-14.23%
|
$0
$0.78 P/Share
|